Evoli, Amelia
Evoli, Amelia
ROMA - Dipartimento di Neuroscienze
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia
2022-01-01 Damato, V.; Papi, C.; Spagni, G.; Evoli, A.; Silvestri, G.; Masi, G.; Sabatelli, E.; Campetella, L.; McKeon, A.; Andreetta, F.; Riso, V.; Monte, G.; Luigetti, M.; Primiano, G.; Calabresi, P.; Iorio, R.
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders
2022-01-01 Punga, Ar; Maddison, P; Heckmann, Jm; Guptill, Jt; Evoli, A
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: A genome-wide association study
2022-01-01 Chia, R.; Saez-Atienzar, S.; Murphy, N.; Chio, A.; Blauwendraat, C.; Roda, R. H.; Tienari, P. J.; Kaminski, H. J.; Ricciardi, R.; Guida, M.; De Rosa, A.; Petrucci, L.; Evoli, A.; Provenzano, C.; Drachman, D. B.; Traynor, B. J.
Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report
2022-01-01 Monte, G.; Evoli, A.; Sanders, D. B.; Modoni, A.
Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience
2022-01-01 Farina, A.; Falso, S.; Cornacchini, S.; Spagni, G.; Monte, G.; Mariottini, A.; Massacesi, L.; Barilaro, A.; Evoli, A.; Damato, V.
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
2021-01-01 Monte, G.; Spagni, G.; Damato, V.; Iorio, R.; Marino, M.; Evoli, A.
Benefit and danger from immunotherapy in myasthenia gravis
2021-01-01 Rodolico, C.; Nicocia, G.; Damato, V.; Antonini, G.; Liguori, R.; Evoli, A.
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis
2021-01-01 Spagni, G.; Todi, L.; Monte, G.; Valentini, M.; Di Sante, G.; Damato, V.; Marino, M.; Evoli, A.; Lantieri, F.; Provenzano, C.
In sickness and in health: when myasthenia gravis is a conjugal matter
2021-01-01 Alboini, P. E.; Spagni, G.; Evoli, A.
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
2021-01-01 Narayanaswami, P.; Sanders, D. B.; Wolfe, G.; Benatar, M.; Cea, G.; Evoli, A.; Gilhus, N. E.; Illa, I.; Kuntz, N. L.; Massey, J.; Melms, A.; Murai, H.; Nicolle, M.; Palace, J.; Richman, D.; Verschuuren, J.
242nd ENMC International Workshop: Diagnosis and management of juvenile myasthenia gravis Hoofddorp, the Netherlands, 1–3 March 2019
2020-01-01 Munot, P.; Robb, S. A.; Niks, E. H.; Palace, J.; Niks, E.; Robb, S.; Evoli, A.; Klein, A.; Cruz, P. R.; Eymard, B.; Jungbluth, H.; Erasmus, C.; Marina, A. D.; Baggi, F.; Kuntz, N.; Borresen, M.; Hughes, I.; Ramdas, S.; Ryan, M.; Pitt, M.
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients
2020-01-01 Piano, C.; Di Stasio, E.; Primiano, G.; Janiri, D.; Luigetti, M.; Frisullo, G.; Vollono, C.; Lucchini, M.; Brunetti, V.; Monforte, M.; Guglielmi, V.; Della Marca, G.; Evoli, A.; Marra, C.; Mirabella, M.; Quaranta, D.; Ricci, E.; Servidei, S.; Silvestri, G.; Bellavia, S.; Bortolani, S.; Bove, F.; Di Iorio, R.; Di Paolantonio, A.; Genovese, D.; Ialongo, T.; Lo Monaco, M. R.; Marotta, J.; Patanella, Ak.; Perna, A.; Petracca, M.; Presicce, G.; Riso, V.; Rollo, E.; Romano, A.; Romozzi, M.; Sancricca, C.; Scala, I.; Spagni, G.; Solito, M.; Tricoli, L.; Zinzi, P.; Calabresi, P.; Bentivoglio, A. R.
Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology
2020-01-01 Iorio, Raffaele; Damato, Valentina; Spagni, Gregorio; Della Marca, Giacomo; Vollono, Catello; Masi, Gianvito; Papi, Claudia; Campetella, Lucia; Monte, Gabriele; Evoli, Amelia
Controversies in Ocular Myasthenia Gravis
2020-01-01 Evoli, A.; Iorio, R.
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America
2020-01-01 Green, J. D.; Barohn, R. J.; Bartoccion, E.; Benatar, M.; Blackmore, D.; Chaudhry, V.; Chopra, M.; Corse, A.; DImachkie, M. M.; Evoli, A.; Florence, J.; Freimer, M.; Howard, J. F.; Jiwa, T.; Kaminski, H. J.; Kissel, J. T.; Koopman, W. J.; Lipscomb, B.; Maestri, M.; Marino, M.; Massey, J. M.; McVey, A.; Mezei, M. M.; Muppidi, S.; Nicolle, M. W.; Oger, J.; Pascuzzi, R. M.; Pasnoor, M.; Pestronk, A.; Provenzano, C.; Ricciardi, R.; Richman, D. P.; Rowin, J.; Sanders, D. B.; Siddiqi, Z.; Soloway, A.; Wolfe, G. I.; Wulf, C.; Drachman, D. B.; Traynor, B. J.
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis
2020-01-01 Marino, Mariapaola; Basile, Umberto; Spagni, Gregorio; Napodano, Cecilia; Iorio, Raffaele; Gulli, Francesca; Todi, Laura; Provenzano, Carlo; Bartoccioni, Emanuela; Evoli, Amelia
Minimal manifestation status and prednisone withdrawal in the MGTX trial
2020-01-01 Lee, I.; Kuo, H. -C.; Aban, I. B.; Cutter, G. R.; McPherson, T.; Kaminski, H. J.; Sussman, J.; Strobel, P.; Oger, J.; Cea, G.; Heckmann, J. M.; Evoli, A.; Nix, W.; Ciafaloni, E.; Antonini, G.; Witoonpanich, R.; King, J. O.; Beydoun, S. R.; Chalk, C. H.; Barboi, A. C.; Amato, A. A.; Shaibani, A. I.; Katirji, B.; Lecky, B. R. F.; Buckley, C.; Vincent, A.; Dias-Tosta, E.; Yoshikawa, H.; Waddington-Cruz, M.; Pulley, M. T.; Rivner, M. H.; Kostera-Pruszczyk, A.; Pascuzzi, R. M.; Jackson, C. E.; Verschuuren, J. J. G.; Massey, J. M.; Kissel, J. T.; Werneck, L. C.; Benatar, M.; Barohn, R. J.; Tandan, R.; Mozaffar, T.; Conwit, R.; Minisman, G.; Sonett, J. R.; Wolfe, G. I.
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
2020-01-01 Huda, Saif; Cao, Michelangelo; De Rosa, Anna; Woodhall, Mark; Rodriguez Cruz, Pedro M; Cossins, Judith; Maestri, Michelangelo; Ricciardi, Roberta; Evoli, Amelia; Beeson, David; Vincent, Angela
An update on Thymectomy in Myasthenia Gravis
2019-01-01 Evoli, A; Meacci, E
Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis
2019-01-01 Sabre, Liis; Evoli, Amelia; Punga, Anna Rostedt
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2022 | Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia | Damato, V.; Papi, C.; Spagni, G.; Evoli, A.; Silvestri, G.; Masi, G.; Sabatelli, E.; Campetella, L.; McKeon, A.; Andreetta, F.; Riso, V.; Monte, G.; Luigetti, M.; Primiano, G.; Calabresi, P.; Iorio, R. | |
| 1-gen-2022 | Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders | Punga, Ar; Maddison, P; Heckmann, Jm; Guptill, Jt; Evoli, A | |
| 1-gen-2022 | Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: A genome-wide association study | Chia, R.; Saez-Atienzar, S.; Murphy, N.; Chio, A.; Blauwendraat, C.; Roda, R. H.; Tienari, P. J.; Kaminski, H. J.; Ricciardi, R.; Guida, M.; De Rosa, A.; Petrucci, L.; Evoli, A.; Provenzano, C.; Drachman, D. B.; Traynor, B. J. | |
| 1-gen-2022 | Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report | Monte, G.; Evoli, A.; Sanders, D. B.; Modoni, A. | |
| 1-gen-2022 | Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience | Farina, A.; Falso, S.; Cornacchini, S.; Spagni, G.; Monte, G.; Mariottini, A.; Massacesi, L.; Barilaro, A.; Evoli, A.; Damato, V. | |
| 1-gen-2021 | Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? | Monte, G.; Spagni, G.; Damato, V.; Iorio, R.; Marino, M.; Evoli, A. | |
| 1-gen-2021 | Benefit and danger from immunotherapy in myasthenia gravis | Rodolico, C.; Nicocia, G.; Damato, V.; Antonini, G.; Liguori, R.; Evoli, A. | |
| 1-gen-2021 | Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis | Spagni, G.; Todi, L.; Monte, G.; Valentini, M.; Di Sante, G.; Damato, V.; Marino, M.; Evoli, A.; Lantieri, F.; Provenzano, C. | |
| 1-gen-2021 | In sickness and in health: when myasthenia gravis is a conjugal matter | Alboini, P. E.; Spagni, G.; Evoli, A. | |
| 1-gen-2021 | International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update | Narayanaswami, P.; Sanders, D. B.; Wolfe, G.; Benatar, M.; Cea, G.; Evoli, A.; Gilhus, N. E.; Illa, I.; Kuntz, N. L.; Massey, J.; Melms, A.; Murai, H.; Nicolle, M.; Palace, J.; Richman, D.; Verschuuren, J. | |
| 1-gen-2020 | 242nd ENMC International Workshop: Diagnosis and management of juvenile myasthenia gravis Hoofddorp, the Netherlands, 1–3 March 2019 | Munot, P.; Robb, S. A.; Niks, E. H.; Palace, J.; Niks, E.; Robb, S.; Evoli, A.; Klein, A.; Cruz, P. R.; Eymard, B.; Jungbluth, H.; Erasmus, C.; Marina, A. D.; Baggi, F.; Kuntz, N.; Borresen, M.; Hughes, I.; Ramdas, S.; Ryan, M.; Pitt, M. | |
| 1-gen-2020 | An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients | Piano, C.; Di Stasio, E.; Primiano, G.; Janiri, D.; Luigetti, M.; Frisullo, G.; Vollono, C.; Lucchini, M.; Brunetti, V.; Monforte, M.; Guglielmi, V.; Della Marca, G.; Evoli, A.; Marra, C.; Mirabella, M.; Quaranta, D.; Ricci, E.; Servidei, S.; Silvestri, G.; Bellavia, S.; Bortolani, S.; Bove, F.; Di Iorio, R.; Di Paolantonio, A.; Genovese, D.; Ialongo, T.; Lo Monaco, M. R.; Marotta, J.; Patanella, Ak.; Perna, A.; Petracca, M.; Presicce, G.; Riso, V.; Rollo, E.; Romano, A.; Romozzi, M.; Sancricca, C.; Scala, I.; Spagni, G.; Solito, M.; Tricoli, L.; Zinzi, P.; Calabresi, P.; Bentivoglio, A. R. | |
| 1-gen-2020 | Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology | Iorio, Raffaele; Damato, Valentina; Spagni, Gregorio; Della Marca, Giacomo; Vollono, Catello; Masi, Gianvito; Papi, Claudia; Campetella, Lucia; Monte, Gabriele; Evoli, Amelia | |
| 1-gen-2020 | Controversies in Ocular Myasthenia Gravis | Evoli, A.; Iorio, R. | |
| 1-gen-2020 | Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America | Green, J. D.; Barohn, R. J.; Bartoccion, E.; Benatar, M.; Blackmore, D.; Chaudhry, V.; Chopra, M.; Corse, A.; DImachkie, M. M.; Evoli, A.; Florence, J.; Freimer, M.; Howard, J. F.; Jiwa, T.; Kaminski, H. J.; Kissel, J. T.; Koopman, W. J.; Lipscomb, B.; Maestri, M.; Marino, M.; Massey, J. M.; McVey, A.; Mezei, M. M.; Muppidi, S.; Nicolle, M. W.; Oger, J.; Pascuzzi, R. M.; Pasnoor, M.; Pestronk, A.; Provenzano, C.; Ricciardi, R.; Richman, D. P.; Rowin, J.; Sanders, D. B.; Siddiqi, Z.; Soloway, A.; Wolfe, G. I.; Wulf, C.; Drachman, D. B.; Traynor, B. J. | |
| 1-gen-2020 | Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis | Marino, Mariapaola; Basile, Umberto; Spagni, Gregorio; Napodano, Cecilia; Iorio, Raffaele; Gulli, Francesca; Todi, Laura; Provenzano, Carlo; Bartoccioni, Emanuela; Evoli, Amelia | |
| 1-gen-2020 | Minimal manifestation status and prednisone withdrawal in the MGTX trial | Lee, I.; Kuo, H. -C.; Aban, I. B.; Cutter, G. R.; McPherson, T.; Kaminski, H. J.; Sussman, J.; Strobel, P.; Oger, J.; Cea, G.; Heckmann, J. M.; Evoli, A.; Nix, W.; Ciafaloni, E.; Antonini, G.; Witoonpanich, R.; King, J. O.; Beydoun, S. R.; Chalk, C. H.; Barboi, A. C.; Amato, A. A.; Shaibani, A. I.; Katirji, B.; Lecky, B. R. F.; Buckley, C.; Vincent, A.; Dias-Tosta, E.; Yoshikawa, H.; Waddington-Cruz, M.; Pulley, M. T.; Rivner, M. H.; Kostera-Pruszczyk, A.; Pascuzzi, R. M.; Jackson, C. E.; Verschuuren, J. J. G.; Massey, J. M.; Kissel, J. T.; Werneck, L. C.; Benatar, M.; Barohn, R. J.; Tandan, R.; Mozaffar, T.; Conwit, R.; Minisman, G.; Sonett, J. R.; Wolfe, G. I. | |
| 1-gen-2020 | SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody | Huda, Saif; Cao, Michelangelo; De Rosa, Anna; Woodhall, Mark; Rodriguez Cruz, Pedro M; Cossins, Judith; Maestri, Michelangelo; Ricciardi, Roberta; Evoli, Amelia; Beeson, David; Vincent, Angela | |
| 1-gen-2019 | An update on Thymectomy in Myasthenia Gravis | Evoli, A; Meacci, E | |
| 1-gen-2019 | Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis | Sabre, Liis; Evoli, Amelia; Punga, Anna Rostedt |